Sharemaestro company-news research for UnitedHealth Group Incorporated (UNHH34), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
Company news sentiment
UNHH34 news sentiment
UnitedHealth Group Incorporated
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
6 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
6 current stories are mapped specifically to UNHH34.
The score uses 5 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.443.
Confidence is 34/100, below the threshold for a firm score.
News history
Daily score and story count over 30 days
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Price and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
News subjects
What is shaping the score
Source mix
Where the evidence comes from
Recurring subjects
Subjects appearing most often
Earlier readings
How the score has changed
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 23:59 | 56 | -4 | 41/100 (0) | 13 (0) | Measured |
| 12 Aug 23:59 | 60 | +1 | 41/100 (+4) | 13 (+3) | Measured |
| 10 Aug 23:59 | 59 | -1 | 37/100 (-1) | 10 (0) | Provisional |
| 09 Aug 23:59 | 60 | +5 | 38/100 (+7) | 10 (+2) | Provisional |
| 08 Aug 23:59 | 55 | +5 | 31/100 (+4) | 8 (-1) | Provisional |
| 05 Aug 23:59 | 50 | +0 | 27/100 (0) | 9 (+1) | Provisional |
| 31 Jul 23:59 | 50 | +0 | 27/100 (+4) | 8 (+1) | Provisional |
| 27 Jul 23:59 | 50 | -2 | 23/100 (-4) | 7 (-3) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
UnitedHealth faces shareholder suit accusing corporate governance failures
[UnitedHealthcare headquarters in Minnetonka, Minnesota, USA] JHVEPhoto/iStock Editorial via Getty Images UnitedHealth Group (UNH [https://seekingalpha.com/symbol/UNH]) is facing an amended shareholder lawsuit that accuses the insurer of knowing about serious governance issues and doing little to ensure compliance, leading to significant losses in stock value. The suit was filed in a Minnesota federal court by the Employees’ Retirement System of the State of Rhode Island and Länsförsäkringar Fondförvaltning AB, a Swedish asset manager. Plaintiffs blame the board and senior company officers. "O
- Published
- 13 Aug 2026 14:18
- News subject
- Capital return
- Why this score
- Legal or regulatory risk
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- High · 42.8% · 0.5d old
- Duplicates
- 1 consolidated
UnitedHealth declares $2.32 dividend
* UnitedHealth (UNH [https://seekingalpha.com/symbol/UNH]) declares $2.32/share quarterly dividend [https://seekingalpha.com/pr/20616162-unitedhealth-group-board-authorizes-payment-of-quarterly-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/UNH/dividends/yield?source=news_bullet] 2.31% * Payable Sept. 22; for shareholders of record Sept. 14; ex-div Sept. 14. * See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/UNH/dividends?source=news_bullet] MORE ON UNITEDHEALTH * UnitedHealth's Medicare Recovery Is Accelerating An
- Published
- 12 Aug 2026 11:04
- News subject
- Capital return
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- High · 26.6% · 1.7d old
- Duplicates
- 1 consolidated
UnitedHealth Stock Soars After Q2 Earnings Beat and Stronger 202
- Published
- 08 Aug 2026 01:29
- News subject
- Earnings
- Why this score
- Beat expectations, Positive market reaction
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- High · 27.6% · 6.1d old
- Duplicates
- 1 consolidated
Why Did UnitedHealth (NYSE:UNH) Report Higher Earnings?
- Published
- 31 Jul 2026 16:28
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · 2.9% · 13.4d old
- Duplicates
- 1 consolidated
UnitedHealth Group Incorporated (UNH) Stock Price, News, Quote & History
- Published
- 27 Jul 2026 08:18
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 17.8d old
- Duplicates
- 1 consolidated
Unitedhealth Group stock hits 52-week high at 385.01 USD
- Published
- 15 Jul 2026 17:10
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 29.4d old
- Duplicates
- 1 consolidated
Earlier company news
UNHH34 news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
August 12, 2026--(BUSINESS WIRE)--The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on September 22, 2026, to all shareholders of record of UNH common stock as of the close of business September 14, 2026. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a healthcare and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the healthcare experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20260812374098/en/ Contacts Investors: investor_relations@uhg.com Media: uhgmedia@uhg.com View Comments
- Published
- 12 Aug 2026 12:00
- Catalyst
- Market update
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Sen. Elizabeth Warren (D-Mass) has criticized the vertical integration in the U.S. healthcare system, arguing that it leads to higher costs for patients and increased profits for large corporations. Warren took to X on Sunday and used UnitedHealth Group Inc. as an example of a company that controls multiple aspects of healthcare, including insurance, pharmacies, and providers. She argued that this consolidation leads to higher costs for patients while increasing corporate profits. She explained this consolidation, highlighting how entities like UnitedHealthcare and Optum Inc. link multiple parts of the care chain from insurance to specialty pharmacy services. Warren added that the same thing also applies to CVS Health Corp. Don't Miss: A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why Still Learning the Market? These 50 Must-Know Terms Can Help You Catch Up Fast "That's not right — and I have a bill to stop it," said Warren as she backed the bipartisan Patients Before Monopolies Act (S. 4509), which she co-sponsored with Sen. Josh Hawley (R-MO). The bill was reintroduced in May after first launching it in 2024. The bill would ban common ownership of insurers and pharmacies and require companies to divest such holdings within a year to boost competition and lower drug prices. Supporters of the bill said that, over time, the conglomerates behind the three major PBMs, UnitedHealth Group, CVS Health and Cigna Group, have come to exercise "control over every link in the prescription drug delivery chain" by both reimbursing pharmacies and owning or operating them. In America, one health care company can own: Your doctor Your pharmacy Your insurance AND the middleman between your pharmacy and insurance. That means more profits for giant companies and higher costs for you. That's not right — and I have a bill to stop it. pic.twitter.com/AkrTo9Zyso — Elizabeth Warren (@SenWarren) August 9, 2026 Trending: Avoid the #1 Investing Mistake: How Your 'Safe' Holdings Could Be Costing You Big Time Warren, Cuban Push For Healthcare Reform Warren's criticism of the healthcare system comes at a time when the cost of healthcare is a major concern for many Americans. Previously, the Senator proposed a wealth tax that could provide children with access to healthcare. She has also been critical of the narrative surrounding self-made billionaires and pushed her ultra-millionaire wealth tax proposal to fund the healthcare program. Story Continues Warren's comments also align with those of billionaire entrepreneur and Costplusdrugs.com CEO Mark Cuban, who argued that companies may be overspending on healthcare due to a lack of visibility into complex insurance contracts. Cuban accused vertically integrated healthcare companies of exploiting employers' reluctance to change, while brokers and consultants may also discourage switches because of the added work. See Also: Skip the Regrets: The Essential Retirement Tips Experts Wish Everyone Knew Earlier. Hence, he urged CEOs to use AI tools such as ChatGPT, Claude, Grok or Gemini to review healthcare contracts and uncover potential issues. UnitedHealth Group recently reported better-than-expected second-quarter results and raised its full-year 2026 earnings guidance, citing progress in simplifying operations, improving affordability and leveraging technology to enhance healthcare services. Image via Shutterstock Read Next: Think you're saving enough for your kids? You might be dangerously off — see why Building Wealth Across More Than Just the Market Building a resilient portfolio means thinking beyond a single asset or market trend. Economic cycles shift, sectors rise and fall, and no one investment performs well in every environment. That's why many investors look to diversify with platforms that provide access to real estate, fixed-income opportunit
- Published
- 10 Aug 2026 23:31
- Catalyst
- Market update
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion
On July 29, UnitedHealth Group (NYSE:UNH) announced a $4 million commitment, funded through the United Health Foundation, to expand the University of Tennessee Health Sciences' health hub network from 5 locations to 13 across the state by the end of 2027, a buildout expected to reach 200,000 Tennessee residents. It's a modest sum for a company this size, but it lands as UnitedHealth works to repair a business that fell apart just a year earlier.UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion Bull Case: Margins Are Turning The Other Way The repair is showing up in the numbers. UnitedHealth's medical care ratio, the share of premiums spent on claims, hit 88.9% in 2025, up from 85.5% in 2024, and operating earnings collapsed from $32 billion to $19 billion as a result. That ratio has since started reversing: it came in at 86.7% in the second quarter, below the 88.5% analysts expected, and management is now guiding to 88% for the full year while aiming to beat it. Second-quarter revenue of $112 billion topped the $110.9 billion analysts projected, and adjusted earnings per share of $6.38 came in well above the $4.90 consensus estimate. UnitedHealth followed that quarter by raising its full-year adjusted EPS guidance to a range of $19.50 to $20, up from its prior forecast of $18.25. The company has also credited restructuring, including exiting unprofitable contracts, and new use of AI to speed up processes. UnitedHealth's revenue has grown 150% over the past 10 years, a run one analysis tied to healthcare spending rising faster than the economy. The stock has climbed nearly 50% over the past year as the turnaround has taken hold. Bear Case: Not Everyone Is Convinced Yet Not every signal points the same way. Berkshire Hathaway bought UnitedHealth stock at an average price around $380 in the second quarter of 2025 and exited the position in the first quarter of 2026 at less than $300, one of the conglomerate's rare recent losses. On a trailing basis, the stock still isn't cheap: at a market cap of $380 billion against trailing net income of $14.9 billion, UnitedHealth carries a trailing price-to-earnings ratio of 25.5, a multiple that assumes the margin recovery continues rather than stalls. One analysis put shares at 23 times estimated future earnings and noted the stock would need to climb roughly another 19% to revisit the $500 level it hasn't traded at since early last year, a bar that leaves little room for the medical care ratio to disappoint the way it did in 2025. What The Numbers Say Now UnitedHealth trades at a forward price-to-earnings ratio of 20.58 as of August 7, a discount to its 25.5 trailing multiple, and a sign the market expects the medical care ratio recovery to continue. Short interest sits at a modest 2.13% of the float, suggesting limited organized betting against the turnaround. The hedge fund count tied to the stock fell from 145 to 130 quarter over quarter, a pullback that runs counter to the stock's rebound. Story Continues A Recovery Still Being Tested UnitedHealth's Tennessee expansion is a small piece of a much larger story: a company trying to prove that 2025's earnings collapse was a pricing problem it has since fixed, not a permanent shift in its cost structure. The second-quarter beat, the raised guidance, and the medical care ratio's drop to 86.7% all support that repair story. But Berkshire's exit at a loss, a trailing P/E still above 25, and a stock priced around 23 times future earnings show the market isn't taking the recovery for granted. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock. READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to I
- Published
- 9 Aug 2026 19:13
- Catalyst
- Market update
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth Group (UNH) Leans On Optum And Medicare Advantage, Is The Stock Already Pricey?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. UnitedHealth Group (UNH) is back in focus after fresh attention on its Medicare Advantage and Optum Health businesses, which are helping offset pressure in commercial insurance and shaping how investors interpret the stock's recent moves. See our latest analysis for UnitedHealth Group. Over the past year, UnitedHealth Group's stock has combined a 21.01% year to date share price return with a 66.60% 1 year total shareholder return. The recent 1 month share price return of 4.13% and 7 day share price return of 1.77% suggest some momentum has cooled despite continued focus on Medicare Advantage, Optum Health and sector wide defensive interest. If you are looking beyond UnitedHealth Group and want to see where capital is flowing across the sector, it is a good time to scan for other healthcare names benefiting from AI driven care models using the 43 healthcare AI stocks. For UnitedHealth Group, that mix of Medicare Advantage strength, Optum Health growth and commercial strain leaves one key issue hanging: Is the recent move mostly about the business itself or a swing in sentiment that valuation now needs to test? Most Popular Narrative: 3.1% Overvalued UnitedHealth Group last closed at $407.08, slightly above the narrative fair value of $395. This frames the current share price as modestly rich versus that storyline. Our thesis centers on the fact that the market is discounting the massive value of Optum (Insight, Health, and Rx). While the insurance arm (UnitedHealthcare) is undergoing a painful but necessary "right-sizing", shedding ~1.4M members to prioritize margins, Optum continues to scale. By buying UNH at a 13x-15x Forward P/E, investors are essentially acquiring the world's most powerful healthcare data ecosystem at a "legacy utility" multiple. Read the complete narrative. Curious what sits behind that Optum centric thesis for UnitedHealth Group? The narrative leans heavily on future cash generation, margin repair and a specific long term earnings profile. The full breakdown explains how those moving pieces relate to a fair value close to $395. Result: Fair Value of $395 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, investors also need to watch for tougher regulatory action on Medicare Advantage and any slowdown in Optum execution that could challenge this UnitedHealth Group narrative. Story Continues Find out about the key risks to this UnitedHealth Group narrative. Another View on UnitedHealth Group's Valuation The user generated narrative concludes that UnitedHealth Group looks 3.1% overvalued at a fair value of $395, yet the SWS DCF model points in the opposite direction. On that view, the stock at $407.08 is trading well below an estimated future cash flow value of $892.98, which frames it as heavily undervalued. The gap between a modest premium to narrative fair value and a large discount to the SWS DCF estimate raises a simple question for investors: Is the market better at pricing UnitedHealth Group off near term earnings and margins, or are long term cash flows being underappreciated? Look into how the SWS DCF model arrives at its fair value.UNH Discounted Cash Flow as at Aug 2026 Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UnitedHealth Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps With sentiment on UnitedHealth Group split between opportunity and concern, it makes sense to move quickly and review the full picture for yourself. To weigh the trade off between its pote
- Published
- 9 Aug 2026 07:14
- Catalyst
- Market update
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Dear UnitedHealth Stock Fans, Mark Your Calendars for July 16
- Published
- 14 Jul 2026 21:04
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- Published
- 12 Jul 2026 08:51
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth Group shares gain on Bank of America upgrade
- Published
- 11 Jul 2026 06:04
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth Just Raised Its Dividend 5%. Why You Should Buy UNH Stock Here.
- Published
- 9 Jul 2026 16:56
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Bank of America Just Upgraded UnitedHealth Stock. Here's Why.
- Published
- 9 Jul 2026 14:58
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth (UNH) Surges Following Q1 Earnings Beat and EPS Gui
- Published
- 22 Jun 2026 09:18
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth Group (UNH) Announces $2B Stock Buyback and Strong Earnings Report
- Published
- 19 Jun 2026 16:48
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
UnitedHealth (UNH) Reports Strong Q1 Earnings, Exceeds Revenue E
- Published
- 19 Jun 2026 15:57
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Provider matches checked
Provider mentions not used in the score
A news provider linked these stories to UNHH34, but the headline and available text are not mainly about UnitedHealth Group Incorporated. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of UNHH34 sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.